Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Cardiology
>
2020
>
48
>
3
Volume:
48
Issue:
3
1. Cardiovascular imaging: past, present and future.
Page:177—180
2. Advancing the clinical application of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in cardiovascular inflammation.
Page:181—185
3. Brief summary of echocardiography development.
Page:186—188
4. Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19.
Page:189—194
5. Expert consensus on blood pressure management in hypertensive disorders of pregnancy (2019).
Page:195—204
6. Value of absolute quantification of myocardial perfusion by PET in detecting coronary microvascular disease in patients with non-obstructive coronaries.
Page:205—210
7. Association between brain glucose metabolism and cardiac dysfunction in patients with ischemic heart disease undergoing (18)F-FDG PET/CT imaging.
Page:211—216
8. Comparison of six-month follow-up results of primary percutaneous coronary intervention guided by optical coherence tomography or coronary angiography.
Page:217—222
9. Relationship between C-reactive protein level and incidence of left atrial spontaneous echocardiographic contrast in patients with nonvalvular atrial fibrillation.
Page:223—227
10. Incidence and risk factors for cardiovascular events in patients hospitalized with community-acquired pneumonia.
Page:228—235
11. Clinical outcomes of opening coronary chronic total occlusion lesions with the assistance of BridgePoint devices.
Page:236—243
12. Current status and changes of disease burden of cardio-cerebrovascular diseases in 1990 and 2016 for Beijing people.
Page:244—249
13. Syncope induced by right ventricular Löffler endocarditis and successful surgical treatment.
Page:250—251
14. Progress of heart failure treatment in 2019.
Page:252—254
15. Research progress on the association between cholesterol efflux capacity and coronary artery disease.
Page:255—258
16. Menopause hormone therapy and prevention of cardiovascular disease.
Page:259—262